MIDAS VERDICT:

Sourcebio is valued at just over £128 million but LeCoque is determined to build the business into a £500 million company. He has delivered similar growth at other health firms in the past and there is every reason to believe that he can do it again at Sourcebio. The company is a recognised and valued supplier to the NHS, it is helping in the battle against coronavirus and is well connected across the healthcare industry. At £1.74, the shares are a buy.